| EPE245 | Cost of caregiver-assisted oral HIV screening of children in Uganda and Zambia | E-poster | Costing of HIV, hepatitis and STI services |
| EPE238 | Cost versus price of key drugs to treat COVID-19, HIV, HBV and HCV | E-poster | Costing of HIV, hepatitis and STI services |
| EPE250 | Cost'benefit analysis of investments made in Morocco since the creation of the Global Fund (2002 - 2020) for HIV control | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
| EPB146 | Cost-effective continuous flow synthesis of HIV second and third generation integrase inhibitor drugs: a step towards local API manufacturing in Africa | E-poster | ART in acute, first- and second-line therapies |
| OAE0303 | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings | Oral abstract session with live Q&A | Economic evaluation and affordability assessments |
| EPE254 | Cost-effectiveness of HIV drug assistance programs in the United States: a systematic review of economic evaluations | E-poster | Economic evaluation and affordability assessments |
| EPE255 | Costs and benefits of community responses for sexual and reproductive health and the societal enablers: a scoping review | E-poster | Economic evaluation and affordability assessments |
| EPE246 | Costs of pharmacy, workplace and hotspot HIV self-testing in Kenya | E-poster | Costing of HIV, hepatitis and STI services |
| EPD018 | Could social media facilitate HIV services promotion among key populations in LMICs? Lessons from a crowdsourced randomized controlled trial | E-poster | Knowledge translation and dissemination of research and programme outcomes |
| EPD325 | Countering fear, phobias, stigma, lack of knowledge: designing and implementing appropriate HIV awareness and testing strategies and interventions for people with hepatitis C - Georgian experience | E-poster | Conceptualizing social and structural factors and their impacts |